Bollard Group’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-621
Closed -$14K 311
2025
Q4
$14K Hold
621
﹤0.01% 256
2025
Q3
$13K Hold
621
﹤0.01% 232
2025
Q2
$9K Buy
621
+30
+5% +$351 ﹤0.01% 261
2025
Q1
$6K Hold
591
﹤0.01% 259
2024
Q4
$7K Hold
591
﹤0.01% 255
2024
Q3
$9K Hold
591
﹤0.01% 269
2024
Q2
$9K Hold
591
﹤0.01% 267
2024
Q1
$10K Hold
591
﹤0.01% 261
2023
Q4
$9K Hold
591
﹤0.01% 263
2023
Q3
$7K Hold
591
﹤0.01% 280
2023
Q2
$6K Hold
591
﹤0.01% 365
2023
Q1
$6K Sell
591
-10,737
-95% -$127K ﹤0.01% 263
2022
Q4
$138K Sell
11,328
-67
-0.6% -$835 0.01% 175
2022
Q3
$141K Sell
11,395
-5,030
-31% -$87.9K 0.01% 177
2022
Q2
$322K Sell
16,425
-4,474
-21% -$106K 0.01% 153
2022
Q1
$545K Buy
20,899
+764
+4% +$20.3K 0.02% 164
2021
Q4
$571K Sell
20,135
-9,004
-31% -$280K 0.02% 164
2021
Q3
$929K Buy
29,139
+3,452
+13% +$116K 0.03% 137
2021
Q2
$891K Sell
25,687
-618
-2% -$20.4K 0.03% 141
2021
Q1
$775K Hold
26,305
0.03% 139
2020
Q4
$807K Hold
26,305
0.03% 130
2020
Q3
$735K Sell
26,305
-63
-0.2% -$1.6K 0.03% 133
2020
Q2
$566K Hold
26,368
0.02% 129
2020
Q1
$590K Sell
26,368
-4,060
-13% -$111K 0.03% 114
2019
Q4
$896K Hold
30,428
0.03% 120
2019
Q3
$809K Sell
30,428
-1,342
-4% -$40.3K 0.03% 123
2019
Q2
$1.07M Sell
31,770
-1
-0% -$32 0.04% 132
2019
Q1
$1.02M Buy
+31,771
New +$978K 0.04% 129

Other funds holding ELAN

Bollard Group's ELAN Position: Q1 2026 in Review

Bollard Group sold out of Elanco Animal Health (ELAN) in Q1 2026, closing a stake of 621 shares — an estimated $14K sold.

Bollard Group first reported a position in ELAN in Q1 2019 and held it in 28 quarters. The position peaked at $1.07M in Q2 2019. 518 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

  • Bollard Group reported no remaining Elanco Animal Health position as of Q1 2026 after selling out during the quarter.
  • Bollard Group sold 621 Elanco Animal Health shares in Q1 2026, an estimated $14K.
  • Bollard Group first reported a position in Elanco Animal Health in Q1 2019 and held it in 28 quarters.
  • Bollard Group's Elanco Animal Health position peaked at $1.07M in Q2 2019.
  • 518 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Bollard Group's 13F filing for Q1 2026, filed 14 May 2026.